Journalism of Courage
Biocon
Follow on:
Biocon Limited: A Pioneer in Indian Biopharmaceuticals Biocon Limited, founded in 1978 by Kiran Mazumdar-Shaw, has established itself as a leading biopharmaceutical company based in Bengaluru. Its operations span a global reach, with generic active pharmaceutical ingredients (APIs) distributed acros...
Image Source : Wikipedia
- Company type Public
- Founded 1978 (47 years ago) (1978)
- Founders Kiran Mazumdar-Shaw
- Headquarters Bangalore, Karnataka, India
- Key people Kiran Mazumdar-Shaw (executive chairperson), Peter Bains (Group CEO), Siddharth Mittal (CEO & (CEO &
- Revenue ₹15,621 crore (US$1.8 billion) (FY24)
- Net income ₹1,030 crore (US$120 million) (FY24)
- Number of employees 16,545 <small>(March 2023)</small>
- Subsidiaries Biocon Biologics, Syngene International
- Website www.biocon.com
Related Other Pages:
Biocon history
Last Updated : 17/03/25, 05:12 AM
Biocon: A Journey in Biopharmaceutical Innovation Founded in 1978 by Kiran Mazumdar-Shaw with a modest US$10,000, Biocon quickly established itself as a pioneer in the Indian biotechnology sector. Early successes included becoming the first Indian company to export enzymes to the US and Europe (1979...
BIOCON NEWS
Antibody for Covid-19 curb, treatment: Biocon Biologics partners with Adagio Therapeutics
July 26, 2021 9:08 pm
ADG20 is in global clinical development by Adagio as a single agent for both the treatment and prevention of Covid-19, the disease caused by the SARS-CoV-2 virus, its variants, as well as future variants that may emerge.
Biocon chief Mazumdar-Shaw donates Rs 5 crore to ILSF for pandemic research
June 10, 2021 9:49 am
The foundation plans to use the donation towards funding research projects on 'Pandemic Preparedness', planned as a supportive effort to handle future pandemics.
Biocon chief Kiran Mazumdar-Shaw expresses concern over COVID-19 vaccine shortage
May 11, 2021 1:16 pm
Biocon Executive Chairman Kiran Mazumdar-Shaw has expressed concern over shortage of COVID-19 vaccines and sought better transparency from the government regarding their availability so that citizens could patiently wait for their turn.
Biocon Q3 net profit falls 19% to Rs 186.6 crore
January 22, 2021 11:45 am
The company's revenue from operations rose to Rs 1,851 crore for the quarter under consideration, up 7.81 per cent, as against Rs 1,716.8 crore during the same period a year ago, Biocon said in a late night regulatory filing on Thursday.
Will take Covid vaccine; confident on safety, efficacy: Kiran Mazumdar-Shaw
December 09, 2020 5:11 pm
A certain section of people may be hesitant to take Covid-19 vaccine but not biotechnology industry veteran Kiran Mazumdar-Shaw.
Biocon Q1 net profit declines 26% to Rs 167.8 crore
July 24, 2020 12:01 pm
Shares of Biocon Ltd were trading at Rs 418.85 per scrip on BSE, down 2.66 per cent from its previous close.
Biocon drug receives DCGI nod for use in moderate to severe COVID-19 patients
July 11, 2020 7:07 pm
Biocon has repurposed Itolizumab, an anti-CD6 IgG1 monoclonal antibody launched in India in 2013 as ALZUMAb for treating chronic plaque psoriasis, for the treatment of CRS in moderate to severe ARDS patients due to COVID-19, the company said.
Biocon’s Kiran Mazumdar-Shaw awarded EY Entrepreneur of the Year for 2019
February 20, 2020 4:36 am
Awards were also announced for nine other categories, a press release said, adding the EY Entrepreneur of The Year Awards is the only global business award programme that is celebrated across 60 countries.
Kiran Mazumdar-Shaw conferred with Australia's highest civilian honour
January 18, 2020 2:18 pm
Mazumdar-Shaw is the fourth Indian citizen to be awarded Australia's highest civilian honour.
Biocon sheds early gains, settles 1 per cent lower
December 03, 2019 5:17 pm
Biotechnology major Biocon and drug firm Mylan NV on Monday announced the launch of biosimilar Ogivri, used for treatment of certain breast and gastric cancers, in the US market.
